Prognostic significance and effect of chemoradiotherapy on microvessel density (angiogenesis) in esophageal Barrett's esophagus-associated adenocarcinoma and squamous cell carcinoma

Human Pathology

Volumn 30, Issue 7, 1999, Pages 753-758

  Torres, Carlos ^b   Wang, Helen ^b   Turner, Jerold ^b   Shahsafaei, Ali ^b   Odze, Robert D ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b NONE

Author keywords

Angiogenesis; Barrett's esophagus; CD31; Neogenesis; Prognosis

Indexed keywords

ADENOCARCINOMA; ADULT; ANGIOGENESIS; ARTICLE; BARRETT ESOPHAGUS; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CLINICAL ARTICLE; DIAGNOSTIC VALUE; ESOPHAGUS CARCINOMA; FEMALE; HUMAN; HUMAN TISSUE; MALE; SQUAMOUS CELL CARCINOMA;

EID: 0032800450     PISSN: 00468177     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0046-8177(99)90135-1     Document Type: Article

References (44)

1. Torres C, Turner JR, Wang HH, et al: Pathologic prognostic factors in Barrett's-associated adenocarcinoma: A follow-up study of 96 patients. Cancer 85:520-528, 1999
2. Ide H, Nakamura T, Hayashi K, et al: Esophageal squamous cell carcinoma: Pathology and prognosis. World J Surg 18:321-330, 1994
3. Daly JM, Earnall LH, Menck HR: National cancer data base report on esophageal carcinoma. Cancer 78:1820-1828, 1996
4. Holscher AH, Bollschweider E, Shneider PM, et al: Prognosis of early esophageal cancer: Comparison between adeno- and squamous cell carcinoma. Cancer 76:178-186, 1995
5. Yoshida Y, Okamura T, Ezaki T, et al: Predictors of postoperative distant recurrences in esophageal carcinoma. Ann Thorac Surg 57:886-889, 1994
6. Kato H, TachimoriY, Watanabe H, et al: Evaluation of the new (1987) TNM classification for thoracic esophageal tumors. Int J Cancer 53:220-223, 1993
7. Folkman J, Shing Y: Angiogenesis. J Biol Chem 267:10931-10934, 1992
8. Folkman J, Long D, Becker F: Growth and metastasis of tumour in organ culture. Cancer 16:453-467, 1963
9. Chung YS, Maeda K, Sowa M: Prognostic value of angiogenesis in gastro-intestinal tumours. Eur J Can 32A:2501-2505, 1996
10. Folkman J: Angiogenesis and breast cancer. J Clin Oncol 12:441-443, 1994
11. Vermeulen PB, Gasparini G, Fox SB, et al: Quantification of angiogenesis in solid human tumours: An international consensus on the methodology and criteria of evaluation. Eur J Cancer 32A:2474-2484, 1996
12. Jacquemier JD, Penault-Llorca FM, Bertucci F: Angiogenesis as a prognostic marker in breast carcinoma with conventional adjuvant chemotherapy: A multiparametric and immunohistochemical analysis. J Pathol 184:130-135, 1998
13. Weidner N: Intratumor microvessel density as a prognostic factor in cancer. AmJ Pathol 147:9-19, 1995
14. Weidner N, Semple SF, Welch WR, et al: Tumour angiogenesis and metastasis: Correlation in invasive breast carcinoma. N Engl J Med 324:1-8, 1991
15. Macchiarini P, Fontanini G, Hardin MJ, et al: Relation of neovasculature to metastasis of non-small-cell lung cancer. Lancet 340:145-146, 1992
16. Weidner N, Carroll PR, Flax J: Tumour angiogenesis correlates with metastasis in invasive prostate carcinoma. Am J Pathol 143:401-409, 1993
17. Gasparini G, Weidner N, Maluta S, et al: Intratumoral microvessel density and p53 protein: Correlation with metastasis in head-and-neck squamous-cell carcinoma. Int J Cancer 55:739-744, 1993
18. Kuwano H, Sonoda K, Yasuda M, et al: Tumor invasion and angiogenesis in early esophageal squamous cell carcinoma. J Surg Oncol 65:188-193, 1997
19. Sarbia M, Bittinger F, Porschen R, et al: Tumor vascularization and prognosis in squamous cell carcinomas of the esophagus. Anticancer Res 16:2117-2122, 1996
20. Tanigawa N, Matsumura M, Amaya H, et al: Tumor vascularity correlates with the prognosis of patients with esophageal squamous cell carcinoma. Cancer 79:220-225, 1997
21. Hermanek RP, Sobin LH: UICC international union against cancer: TNM Classification of Malignant Tumors (ed 4). London, England, Springer-Verlag, 1987, pp 40-42
22. Harrison JC, PatrickJD, El-Zeky F, et al: From Dukes through Jass: Pathological prognostic indicators in rectal cancer. HUM PATHOL 25:498-505, 1994
23. Torres CM, Wang HH, Turner JR, et al: Pathologic prognostic factors in esophageal squamous cell carcinoma: A follow-up study of 74 patients with or without preoperative chemoradiation therapy. Mod Pathol (in press)
24. Zetter BR: Angiogenesis and tumor metastasis. Annu Rev Med 49:407-424, 1998
25. Dvorak HF, Brown KF, Detmar M, et al: Vascular permeability factor/vascular endothelial growth factor, microvascular hyperpermeability, and angiogenesis. Am J Pathol 146:1029-1039, 1995
26. Butler TP, Gullino PM: Quantitation of cell shedding into efferent blood of mammary adenocarcinoma. Cancer Res 35:512-516, 1975
27. Taylor S, Folkman J: Protamine is an inhibitor of angiogenesis. Nature 297:307-312, 1982
28. Walsh TN, Noonan N, Hollywood D, et al: A comparison of multimodal therapy and surgery for esophageal adenocarcinoma. N Engl J Med 335:462-467, 1996
29. Mahoney JL, Condon RE: Adenocarcinoma of the esophagus. Ann Surg 205:557-562, 1987
30. Turner J, Torres C, Wang H, et al: Effect of preoperative chemo/radiotherapy on prognostic significance of adhesion molecule expression in Barrett's-associated adenocarcinoma. Mod Pathol 11:72A, 1998
31. Brooks PC: Cell adhesion molecules in angiogenesis. Cancer Metast Rev 15:187-194, 1996
32. Brooks PC, Clark RA, Cheresh DA: Requirement of vascular integrin alpha v beta 3 for angiogenesis. Science 264:569-571, 1994
33. Gasparini G, Bevilacqua P, Bonoldi E, et al: Predictive and prognostic markers in a series of patients with head and neck squamous cell invasive carcinoma treated with concurrent chemoradiation therapy. Clin Cancer Res 1:1375-1383, 1995
34. Gasparini G, Presta M: Clinical studies with angiogenesis inhibitors: Biological rationale and challenges for their evaluation. Ann Oncol 7:441-444, 1996
35. Yoshikawa A, Saura R, Matsubara T, et al: A mechanism of cisplatin action: Antineoplastic effect through inhibition of neovascularization. KobeJ Med Sci 43:109-120, 1997
36. Klauber N, Parangi S, Flynn E, et al: Inhibition of angiogenesis and breast cancer in mice by the microtubule inhibitors 2-methoxyestradiol and taxol. Cancer Res 57:81-86, 1997
37. Kondo M, Satoh Y, Une Y, et al: Suppression of liver metastases by combination of angiogenesis inhibitor TNP-470 and 5-fluorouracil (5-Fu) in mice. Proc Annu Meet Am Assoc Cancer Res 37:A292, 1996
38. Fujioka T, Kamoto T, Ohhori T, et al: Anti-tumor effect of the angiogenesis inhibitor TN-470 (AGM-1740) and its combination effect with chemotherapy in murine renal cell carcinoma. Proc Annu Meet Am Assoc Cancer Res 36:A620, 1995
39. Kato T, Sato K, Kakinuma H, et al: Enhanced suppression of tumor growth by combination of angiogenesis inhibitor O-(chloroacetyl-carbamoyl) fumagillol (TNP-470) and cytotoxic agents in mice. Cancer Res 54:5143-5147, 1994
40. Igarashi M, Dhar DK, Kubota H, et al: The prognostic significance of microvessel density and thymidine phosphorylase expression in squamous cell carcinoma of the esophagus. Cancer 82:1225-1232, 1998
41. Inoue K, Ozeki Y, Suganuma T, et al: Vascular endothelial growth factor expression in primary esophageal squamous cell carcinoma: Association with angiogenesis and tumor progression. Cancer 79:206-213, 1997
42. Leedy DA, Trune DR, Kronz JD, et al: Tumor angiogenesis, the p53 antigen, and cervical metastasis in squamous carcinoma. Otolaryngol Head Neck Surg 111:417-422, 1994
43. Kuwano H, Sonoda K, Yasuda M, et al: Tumor invasion and angiogenesis in early esophageal squamous cell carcinoma. J Surg Oncol 65:188-183, 1997
44. Parums DV, Cordell Jl, Micklem K, et al: JC70: A new monoclonal antibody that detects vascular endothelium associated antigen on routinely processed tissue sections. J Clin Pathol 147:9-19, 1995